Should protracted withdrawal from drugs be included in DSM-IV?
about
Alpha2-adrenergic agonists for the management of opioid withdrawalAlpha2-adrenergic agonists for the management of opioid withdrawalOpioid antagonists with minimal sedation for opioid withdrawalBuprenorphine for the management of opioid withdrawalOpioid antagonists under heavy sedation or anaesthesia for opioid withdrawalAlpha 2 -adrenergic agonists for the management of opioid withdrawalOpioid antagonists with minimal sedation for opioid withdrawalOpioid antagonists under heavy sedation or anaesthesia for opioid withdrawalLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatmentInsomnia, self-medication, and relapse to alcoholismAlcohol's effects on sleep in alcoholicsProtracted manifestations of acute dependence after a single morphine exposure.Vaccines for cocaine abuseCraving among long-abstinent smokers: an Internet surveyOpioid antagonists under sedation or anaesthesia for opioid withdrawal.A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.Evidence-based addiction medicine: the use of lofexidine for opioid detoxification.Cerebral metabolism and mood in remitted opiate dependence.Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol.Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.Aggressive behavior among military veterans in substance use disorder treatment: the roles of posttraumatic stress and impulsivity.Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.Motivational Processes Underlying Substance Abuse Disorder.Serum cortisol secretion during heroin abstinence is elevated only nocturnally.Risk of Hospital Readmission Among Infants With Neonatal Abstinence Syndrome.Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant.Buprenorphine for managing opioid withdrawal.Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.Predicting completion of outpatient opioid detoxification with clonidine.Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.Stimulant withdrawal.Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal.The apomorphine test in heroin addicts.The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.Effects of haloperidol in a response-reinstatement model of heroin relapse.The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects.Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.Alexithymia and personality dimensions in relation to depression and anxiety in male alcohol-dependent inpatients.The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls
P2860
Q24185795-B69B171C-C60A-401C-B096-1FD9BFC996ECQ24197769-DFC62B96-80F2-4896-B1DA-B2B22F2D24E4Q24240041-FBEBB85B-7B7E-46EB-9424-37753BAAC54BQ24240149-B98AAA22-B801-4A57-B448-8A9844D02587Q24240954-63C09CDC-E215-4DCA-B831-DB4D5B29E49BQ24241305-465D83B5-2A61-4EEB-B0F7-5BDFD0607F45Q24244653-C7C0866E-C6FA-4EBB-98D2-E68E553F4AB7Q24246081-C45CC066-5893-4E55-A338-AC682962A52CQ24598228-5E9D92CC-14C3-42B6-84D8-1C343F81884CQ24681779-A5B863FB-A2C7-4CA1-9F6E-548B314A0FFCQ28354377-2FB5380A-DC6C-4D06-8955-E3B90B117FE9Q28360988-AA7E939D-5F22-4E9B-A7D5-E228BE30E6C0Q30440436-41193139-102C-40FF-B6E6-2C02FE57E058Q33883673-58504CE3-3944-4C4C-9077-5EDCFE4297AFQ33988978-822DEEA3-19C3-4231-9E48-B69EA2EE68E3Q34202486-66853240-66C3-4BC8-AEA2-E8677EB50611Q34417561-2DB01AAD-ECC4-437A-89DA-DB5AB4C0A95EQ34444149-3542F1B2-0804-47BA-89F3-2C4DA7518443Q34631150-2A9BB1A0-BCDB-4993-8992-FEBCA0BEFE6AQ35934883-CF62424F-B236-42EE-B1E2-7D8A61D38858Q36123234-1F2A4716-02FE-4124-8F14-5576AB99DF1AQ36216488-BEA4F7AD-3D0D-4B60-9C9D-C97C2489FA96Q36575862-328E3EAF-A217-4064-8098-A94A44192220Q36853330-9D9908E5-5C17-4C5F-A0AE-1A5F13B47680Q36939580-2F5EA34B-4F45-4549-8FEA-CC1936984992Q37415518-5E658705-95EA-43FC-85C4-D6A3CB9CA32CQ38600584-DEE887B5-191B-4425-B251-9CCFE7286533Q38950890-F7C52EC2-1D26-4F44-8A29-4B18E069EA4AQ39670912-22273B54-D597-4535-905A-D395E67FEFE5Q40576026-C46223A1-E94F-4CD9-8C19-71F612E3D246Q40582981-E2D27563-119D-471C-9C52-8627A6823798Q40582992-4A2AF029-4EEC-46A5-BEAE-562569EE717CQ41191250-7A371ED4-F7AF-4539-AAC2-4914F3AAD74AQ41678771-6467C2CB-6276-44E3-A21B-F16759972D2FQ41996190-8047FBAD-DCE5-45FA-B9C1-73F70A3FB716Q43432977-9C3982BF-C2A7-4CCA-B9D4-1280135B56BBQ46953419-765EB339-A47F-4BED-B6D1-9A35D6F277E2Q51621560-CDE8E605-34EA-4C14-99AB-4510408B8A75Q51873685-19CA5D60-4B9C-4959-8B93-D39415AF479CQ55887262-03200ACA-CCAF-4B8B-BE44-51E6D786690C
P2860
Should protracted withdrawal from drugs be included in DSM-IV?
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Should protracted withdrawal from drugs be included in DSM-IV?
@ast
Should protracted withdrawal from drugs be included in DSM-IV?
@en
Should protracted withdrawal from drugs be included in DSM-IV?
@nl
type
label
Should protracted withdrawal from drugs be included in DSM-IV?
@ast
Should protracted withdrawal from drugs be included in DSM-IV?
@en
Should protracted withdrawal from drugs be included in DSM-IV?
@nl
prefLabel
Should protracted withdrawal from drugs be included in DSM-IV?
@ast
Should protracted withdrawal from drugs be included in DSM-IV?
@en
Should protracted withdrawal from drugs be included in DSM-IV?
@nl
P2093
P356
P1476
Should protracted withdrawal from drugs be included in DSM-IV?
@en
P2093
P304
P356
10.1176/AJP.150.5.695
P407
P577
1993-05-01T00:00:00Z